Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-12 5:09 pm Sale | 2025-12-10 | 13D | CureVac N.V. CVAC | Dr. Matthias Hothum | 0 0.000% | -70,280,385 (Position Closed) | Filing History |
| 2025-12-12 4:01 pm Sale | 2025-12-10 | 13D | CureVac N.V. CVAC | dievini Hopp BioTech holding GmbH & Co. KG | 0 0.000% | -82,373,544 (Position Closed) | Filing History |
| 2025-12-12 1:40 pm Sale | 2025-12-10 | 13D | CureVac N.V. CVAC | KfW | 0 0.000% | -112,841,355 (Position Closed) | Filing History |
| 2025-12-05 4:23 pm Sale | 2025-12-03 | 13D | CureVac N.V. CVAC | GSK plc | 0 0.000% | -16,591,937 (Position Closed) | Filing History |
| 2025-08-13 6:05 pm Unchanged | 2025-08-07 | 13D | CureVac N.V. CVAC | GSK plc | 16,591,937 74.000% | 0 (Unchanged) | Filing History |
| 2025-08-01 7:10 pm Sale | 2025-08-01 | 13D | CureVac N.V. CVAC | KfW | 112,841,355 50.100% | -1,348,691 (-1.18%) | Filing History |
| 2025-06-16 4:01 pm Sale | 2025-06-12 | 13D | CureVac N.V. CVAC | dievini Hopp BioTech holding GmbH & Co. KG | 82,373,544 36.700% | -1,507,391 (-1.80%) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | CureVac N.V. CVAC | RA CAPITAL MANAGEMENT L.P. | 2,744,270 1.200% | -9,501,685 (-77.59%) | Filing History |
| 2024-02-06 5:10 pm Purchase | 2023-12-31 | 13G | CureVac N.V. CVAC | GSK plc | 16,591,937 7.400% | 1,656,216 (+11.09%) | Filing History |
| 2023-03-27 5:00 pm Purchase | 2023-03-15 | 13G | CureVac N.V. CVAC | RA CAPITAL MANAGEMENT L.P. | 12,245,955 5.500% | 12,245,955 (New Position) | Filing History |
| 2023-02-24 4:36 pm Sale | 2023-02-23 | 13D | CureVac N.V. CVAC | Dr. Matthias Hothum | 70,280,385 31.700% | -661,651 (-0.93%) | Filing History |
| 2023-02-24 4:35 pm Sale | 2023-02-23 | 13D | CureVac N.V. CVAC | von Bohlen und Halback Friedrich | 469,764 0.200% | -30,180 (-6.04%) | Filing History |
| 2023-02-24 4:33 pm Sale | 2022-02-23 | 13D | CureVac N.V. CVAC | Hettich Christof | 302,268 0.100% | -716,967 (-70.34%) | Filing History |
| 2023-02-24 4:31 pm Sale | 2023-02-23 | 13D | CureVac N.V. CVAC | dievini Hopp BioTech holding GmbH & Co. KG | 83,880,935 37.800% | -664,772 (-0.79%) | Filing History |
| 2023-02-24 2:35 pm Sale | 2023-02-23 | 13D | CureVac N.V. CVAC | KfW | 114,190,046 51.440% | -1,411,919 (-1.22%) | Filing History |
| 2023-02-13 11:41 am Unchanged | 2023-02-10 | 13D | CureVac N.V. CVAC | KfW | 115,601,965 52.080% | 0 (Unchanged) | Filing History |
| 2022-11-14 4:02 pm Sale | 2022-11-08 | 13D | CureVac N.V. CVAC | dievini Hopp BioTech holding GmbH & Co. KG | 84,545,707 45.200% | -1,614,683 (-1.87%) | Filing History |
| 2022-11-14 4:02 pm Sale | 2022-11-08 | 13D | CureVac N.V. CVAC | Dr. Matthias Hothum | 70,942,036 37.900% | -12,021,465 (-14.49%) | Filing History |
| 2022-11-14 4:02 pm Unchanged | 2022-11-08 | 13D | CureVac N.V. CVAC | von Bohlen und Halback Friedrich | 499,944 0.300% | 0 (Unchanged) | Filing History |
| 2022-11-14 4:01 pm Unchanged | 2022-11-08 | 13D | CureVac N.V. CVAC | Hettich Christof | 1,019,235 0.500% | 0 (Unchanged) | Filing History |